Description
CLINICAL PHARMACOLOGY
Artica DHB 100 has been demonstrated to bind extremely well and selectively to the androgen receptor and stimulates androgen receptor transactivation of dependent reporter genes. This equates to a drug that possesses the ability to stimulate significant muscle growth while not producing androgenic side effects. Artica DHB 100 has been shown to be far more anabolic than such compounds as boldenone, nandrolone, and even testosterone itself. Obviously this is of great benefit to many athletes and bodybuilders.
INDICATION
– Structurally identical to methenolone, except for the 1-methylation of methenolone.
– Structurally identical to testosterone, except for a double bond between C-1 and C-2 in its A-ring that has instead moved between C-4 and C-5.
– Structurally identical to boldenone, except for stereospecific break of the double bond between C-1 and C-2 (Boldenone has double bond between both C-1==C-2 and C-4==C-5).